Welcome to our dedicated page for ALLSTATE SEC filings (Ticker: ALL), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The Allstate Corporation filings document the insurer's operating results, Regulation FD updates, governance matters and registered capital structure. Recent Form 8-K reports include quarterly and annual financial results, investor supplements, estimated catastrophe losses and policies in force for Allstate Protection.
Allstate's proxy materials describe board matters, executive compensation and shareholder voting items. Its filing cover pages identify common stock, fixed-to-floating subordinated debentures due 2053, and depositary shares representing Series H, Series I and Series J noncumulative preferred stock registered on public exchanges.
The Allstate Corporation executive Christine M. DeBiase reported routine equity compensation activity in company stock. On February 3, 2026, previously awarded restricted stock units converted into 2,538 shares of Allstate common stock at $0 exercise price under the 2019 Equity Incentive Plan. To cover tax withholding, 1,071 shares of common stock were withheld or disposed of at a price of $201.77 per share. After these transactions, DeBiase directly owned 5,191.904 shares of Allstate common stock.
The Allstate Corporation Chairman, President and CEO Thomas J. Wilson reported multiple open-market sales of Allstate common stock on February 2, 2026. The transactions, coded as sales, covered blocks of 1,605, 1,572, 13,271 and 359 shares at weighted average prices between $198.7714 and $201.5107, with actual trade prices ranging from $198.23 to $201.655.
These sales were executed under a Rule 10b5-1 trading plan adopted on June 27, 2025. After the reported sales, Wilson directly owned 77,601.303 Allstate common shares and also had indirect beneficial holdings through several GRATs, a 401(k) plan, and a remainder trust.
The Allstate Corporation filed a current report to furnish its press release announcing financial results for the fourth quarter and full year of 2025. The company also furnished a fourth quarter 2025 investor supplement, both as exhibits to the report, providing more detailed financial and operating information.
Allstate Corporation director Monica J. Turner reported an equity award transaction. On 02/01/2026, 456 restricted stock units converted into 456 shares of Allstate common stock at a price of $0.00 per share under the 2017 Equity Compensation Plan for Non-Employee Directors.
Following the conversion, Turner directly owns 456 shares of Allstate common stock and no longer holds the 456 restricted stock units, reflecting a shift from derivative to outright share ownership rather than a market sale or purchase.
The Allstate Corporation filed a Form 8-K to inform investors that its December 2025 monthly release is available. This release provides estimated catastrophe losses and the number of policies in force, giving insight into recent claims activity and current insurance exposure.
The company states that the release is posted on allstateinvestors.com and is also included as Exhibit 99 to this report. The exhibit is furnished, not filed, under Regulation FD, meaning it is meant for broad public disclosure rather than updating certain legal filings.
The Allstate Corporation’s Chairman, President & CEO Thomas J. Wilson reported multiple open-market sales of company common stock on January 12, 2026. Across several trades coded as sales, he sold a total of 16,807 shares at weighted average prices ranging from $205.6779 to $209.9939, with actual sale prices spanning from $205.30 to $210.42.
The filing notes that these transactions were carried out under a Rule 10b5-1 trading plan adopted on June 27, 2025, indicating they were pre-arranged. Following the reported sales, Wilson directly beneficially owns 94,408.303 shares of Allstate common stock. He also reports indirect holdings, including 31,900 shares held by a 2024-C GRAT and 69,822 shares held by a 2025-A GRAT, along with additional trust and plan positions.
Allstate Corporation executive Suren Gupta, President, Enterprise Solutions, reported an employee stock option exercise and related stock sale. On January 7, 2026, he exercised an employee stock option for 19,593 shares of Allstate common stock at an exercise price of $62.32 per share and acquired the underlying shares. On the same date, he reported selling 19,593 shares of Allstate common stock at a reported price of $210 per share.
After these transactions, Gupta directly owned 100,646 shares of Allstate common stock. He also had indirect holdings of 1,335 shares through a 401(k) plan and 7 shares through VVG Holdings LLC.
Form 144 shows that Suren K. Gupta plans to sell 19,593 shares of common stock through Fidelity Brokerage Services on the NYSE, with an aggregate market value of $4,114,530.00. The issuer has 261,681,708 shares outstanding, and the sale is expected around 01/07/2026.
The shares come from stock options granted on 02/11/2016 and acquired for cash on 01/07/2026. The filing also lists several prior sales of common stock during November 2025, including 21,871 shares sold on 11/21/2025 for $4,706,912.59, indicating ongoing share disposals by the same seller.
The Allstate Corporation’s Chairman, President and CEO Thomas J. Wilson reported multiple open-market sales of Allstate common stock on January 2, 2026. The Form 4 shows four sale transactions of common stock at weighted average prices of $204.0964, $204.8644, $206.1694, and $206.9005, with corresponding post-transaction direct beneficial ownership levels of 120,826.303, 113,590.303, 112,450.303, and 111,215.303 shares.
The filing states these sales were executed under a Rule 10b5-1 trading plan adopted on June 27, 2025. It also notes that Wilson’s holdings include additional indirect ownership through several GRATs, a 401(k) plan, and a GRAT remainder trust, reflecting substantial ongoing equity exposure to Allstate.
The Allstate Corporation director reports routine stock compensation. On 01/01/2026, director Jacques P. Perold acquired 204 shares of Allstate common stock at $208.15 per share. The shares were received under The Allstate Corporation 2017 Equity Compensation Plan for Non-Employee Directors as stock in lieu of cash compensation. After this transaction, he beneficially owned 204 Allstate shares directly and 35 shares indirectly through a trust.